Bioprocessing Technology Institute (BTI)
A*STAR researchers tackle the challenge of creating therapeutic antibodies that effectively kill tumours and are also easily scalable in manufacturing settings.
Researchers develop an analytical technique to combat food fraud by accurately profiling and differentiating meat samples based on their unique glycan profiles.
A new method to remove a toxic compound from cottonseed could unlock a readily available source of nutritious plant-based protein.
A*STAR researchers develop a high-efficiency technique for scaling up stem cell manufacturing for clinical and research applications.
A*STAR scientists decipher how a stem cell-based treatment stops the uncontrolled inflammation associated with severe COVID-19 cases.
Multidisciplinary efforts across A*STAR are paving the way toward Singapore’s precision medicine vision.
A*STAR researchers discover a mechanism that fires up the metabolism of cancer-killing immune cells, paving the way for future cancer immunotherapies.
Scientists create a platform for reliably customising antibody molecular structures, opening the door to more potent and effective antibody medicines.
A new streamlined method for purifying lab-grown viruses could accelerate vaccine production, allowing manufacturers to respond rapidly to emerging viral threats
From music streaming technology to COVID-19 tests, A*STAR Assistant Chief Executive (Enterprise) Sze Wee Tan details how the agency is bringing their innovations out of the lab and into the real world.
Through the years, A*STAR has always stood at the forefront of science and technology and innovation. Here’s how A*STAR came to be and what it has in store in the upcoming decades.
Using whole-exome sequencing, scientists have identified a gene likely linked to a common eye disorder that can lead to blindness in the elderly.